These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34965962)

  • 1. The Immunomodulatory Enzyme IDO2 Mediates Autoimmune Arthritis through a Nonenzymatic Mechanism.
    Merlo LMF; Peng W; DuHadaway JB; Montgomery JD; Prendergast GC; Muller AJ; Mandik-Nayak L
    J Immunol; 2022 Feb; 208(3):571-581. PubMed ID: 34965962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses.
    Merlo LMF; DuHadaway JB; Montgomery JD; Peng WD; Murray PJ; Prendergast GC; Caton AJ; Muller AJ; Mandik-Nayak L
    Front Immunol; 2020; 11():1861. PubMed ID: 32973768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis.
    Merlo LMF; Pigott E; DuHadaway JB; Grabler S; Metz R; Prendergast GC; Mandik-Nayak L
    J Immunol; 2014 Mar; 192(5):2082-2090. PubMed ID: 24489090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of IDO1 and IDO2 on the B Cell Immune Response.
    Merlo LMF; Peng W; Mandik-Nayak L
    Front Immunol; 2022; 13():886225. PubMed ID: 35493480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDO2 Modulates T Cell-Dependent Autoimmune Responses through a B Cell-Intrinsic Mechanism.
    Merlo LM; DuHadaway JB; Grabler S; Prendergast GC; Muller AJ; Mandik-Nayak L
    J Immunol; 2016 Jun; 196(11):4487-97. PubMed ID: 27183624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.
    Metz R; Smith C; DuHadaway JB; Chandler P; Baban B; Merlo LM; Pigott E; Keough MP; Rust S; Mellor AL; Mandik-Nayak L; Muller AJ; Prendergast GC
    Int Immunol; 2014 Jul; 26(7):357-67. PubMed ID: 24402311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis.
    Merlo LMF; Grabler S; DuHadaway JB; Pigott E; Manley K; Prendergast GC; Laury-Kleintop LD; Mandik-Nayak L
    Clin Immunol; 2017 Jun; 179():8-16. PubMed ID: 28223071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
    Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
    Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity.
    Merlo LM; Mandik-Nayak L
    Clin Med Insights Pathol; 2016; 9(Suppl 1):21-28. PubMed ID: 27891058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
    PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer.
    Kado SY; Bein K; Castaneda AR; Pouraryan AA; Garrity N; Ishihara Y; Rossi A; Haarmann-Stemmann T; Sweeney CA; Vogel CFA
    Cells; 2023 May; 12(10):. PubMed ID: 37408267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.
    Napolioni V; Pariano M; Borghi M; Oikonomou V; Galosi C; De Luca A; Stincardini C; Vacca C; Renga G; Lucidi V; Colombo C; Fiscarelli E; Lass-Flörl C; Carotti A; D'Amico L; Majo F; Russo MC; Ellemunter H; Spolzino A; Mosci P; Brancorsini S; Aversa F; Velardi A; Romani L; Costantini C
    Front Immunol; 2019; 10():890. PubMed ID: 31134053
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
    Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-44. PubMed ID: 19402226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.
    Trabanelli S; Očadlíková D; Ciciarello M; Salvestrini V; Lecciso M; Jandus C; Metz R; Evangelisti C; Laury-Kleintop L; Romero P; Prendergast GC; Curti A; Lemoli RM
    J Immunol; 2014 Feb; 192(3):1231-40. PubMed ID: 24391212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function.
    Suvieri C; De Marchis F; Mandarano M; Ambrosino S; Rossini S; Mondanelli G; Gargaro M; Panfili E; Orabona C; Pallotta MT; Belladonna ML; Volpi C
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of the First Selective IDO2 Inhibitor As Novel Immunotherapeutic Avenues for Rheumatoid Arthritis.
    He G; Wan S; Wu Y; Chu Z; Shen H; Zhang S; Chen L; Bao Z; Gu S; Huang J; Huang L; Gong G; Zou Y; Zhu Q; Xu Y
    J Med Chem; 2022 Nov; 65(21):14348-14365. PubMed ID: 35952367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low efficiency IDO2 enzymes are conserved in lower vertebrates, whereas higher efficiency IDO1 enzymes are dispensable.
    Yuasa HJ; Mizuno K; Ball HJ
    FEBS J; 2015 Jul; 282(14):2735-45. PubMed ID: 25950090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.
    Lee A; Kanuri N; Zhang Y; Sayuk GS; Li E; Ciorba MA
    PLoS One; 2014; 9(12):e115848. PubMed ID: 25541686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD+ and inhibits in vivo tumor growth.
    Liu Y; Zhang Y; Zheng X; Zhang X; Wang H; Li Q; Yuan K; Zhou N; Yu Y; Song N; Fu J; Min W
    Oncotarget; 2016 May; 7(22):32329-40. PubMed ID: 27058624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.